SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : CYPT It's Real
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scion who wrote (293)1/11/2004 12:40:36 PM
From: scion  Read Replies (1) of 365
 
This Amendment No. 3 to Schedule 13D relates to
common stock of Calypte Biomedical Corporation (the "Company").

This Amendment No. 3 amends the initial statement on Schedule 13D ("Initial Statement") filed
with the Securities and Exchange Commission on September 8, 2003 by Marr
Technologies BV ("MTBV") and Amendments No. 1 and No. 2 to the Initial Statement
(the "Amendments") filed with the Securities and Exchange Commission on October
1, 2003 and October 8, 2003, respectively, by MTBV. Entities and individuals
that could be deemed to share voting and dispositive power due to their direct
or indirect ownership of MTBV were inadvertently not included in previous
filings. The Initial Statement and the Amendments are amended as follows:

Item 2. Identity and Background
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News